Abstract
ObjectiveTo determine the possible risk factors associated with hepatic dysfunction during open-heart surgeries.MethodsAfter excluding 71 patients, 307 patients with possible low and moderate cardiac risk who underwent either coronary artery bypass graft surgery (CABG) (n=176) or valve repair surgery (mitral valve, mitral and aortic valves and/or tricuspid valve) (n=131) were investigated prospectively during a 6-month period. Hyperbilirubinemia is defined as an occurrence of a plasma total bilirubin concentration >34 µmol/L (2 mg/dL) in any measurement during the postoperative period; the patients were divided into groups with or without postoperative hyperbilirubinemia. The collected parameters were: alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), total bilirubin (TBil), gamma-glutamyl transpeptidase (GGT) and albumin. The parameters were collected preoperatively and postoperatively on days 1, 3 and 7. Preoperative, intraoperative, and postoperative risk factors were investigated. Logistic regression analysis was performed to identify the risk factors for postoperative hyperbilirubinemia.ResultsPostoperative hyperbilirubinemia was observed in 7 of 176 patients (4%) who underwent CABG, and in 11 of 131 patients (8.4%) who underwent valve replacement surgeries. Independent risk factors for early postoperative hyperbilirubinemia were found as: ejection fraction (EF), aortic cross-clamp (ACC) time, intensive care unit stay and extubation time (P<0.001). In comparison to CABG procedures, postoperative hyperbilirubinemia was observed more frequently in patients undergoing valve surgeries (P=0.027).ConclusionLow EF and prolonged ACC time are significant independent risk factors for early postoperative hyperbilirubinemia during open-heart surgeries with cardiopulmonary bypass. Valve surgeries show a higher incidence of hyperbilirubinemia in comparison to CABG.
Highlights
There are a series of pathophysiological changes in patients undergoing open-heart surgeries with cardiopulmonary bypass (CPB) that cause liver hypoperfusion, centrilobular sinusoid ischemia, and subsequent reperfusion injuries, hemolysis, or systemic inflammatory response
Seventyone patients were excluded for possible high cardiac risk factors and the study was performed on 307 patients
Depending on the methods and definition of hyperbilirubinemia in the postoperative period, patients were divided into groups with or without postoperative hyperbilirubinemia
Summary
There are a series of pathophysiological changes in patients undergoing open-heart surgeries with cardiopulmonary bypass (CPB) that cause liver hypoperfusion, centrilobular sinusoid ischemia, and subsequent reperfusion injuries, hemolysis, or systemic inflammatory response. These events may eventually lead to various forms of hepatic dysfunction in patients during the postoperative period after open-heart surgeries[1]. The incidence of postoperative hyperbilirubinemia ranged from 20% to 51% in open-heart surgeries with CPB The causes of this higher incidence were related to the presence of various possible risk factors, among them: valvular heart disease and low cardiac output causing hemodynamical instability, and low ejection fraction (EF). We can list these factors as: heart function with poor preoperative clinical and echocardiographic findings, hemodynamic instability, emergency surgery, and laboratory findings of poor preoperative liver dysfunction[5,6,7,8]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have